BACTILOC CV-100
MRP: 188
Packaging: 30 ML
Pack Type: dry-syrup
Composition:
Cefpodoxime 100mg + Eq. to Clavulanic Acid 62.5 mg
Indication:
Pharyngitis, Tonsillitis, Pneumonia, Bronchitis, ICU & SSTI, Typhoid & Fever, Acute otitis media
Description:
This combination features Cefpodoxime Proxetil, a third-generation cephalosporin, with Clavulanic Acid, a beta-lactamase inhibitor. Together, they offer broad-spectrum, β-lactamase-resistant antibacterial activity, making them highly effective against resistant pathogens in respiratory and urinary tract infections, ENT, and skin conditions.
Tags:
- Effective against resistant β-lactamase-producing bacteria
- Enhanced therapeutic coverage for ENT, respiratory & skin infections
- Suitable for pediatric and adult patients
- Quick symptom relief and high patient compliance
- Excellent safety and tolerance profile
Usage Information
Dosage
Upper and lower respiratory tract infections Tonsillitis, pharyngitis, otitis media Sinusitis Bronchitis, pneumonia Skin & soft tissue infections Urinary tract infections
Side Effects
For Pediatric Dry Syrup (100mg/62.5mg per 5ml) Typical dose: 10 mg/kg/day in two divided doses Shake well before use Use reconstituted suspension within 7 days Example Dose (child 10 kg): 5 ml twice daily = 200 mg Cefpodoxime + 125 mg Clavulanic Acid per day For Tablets (Adult Use) 1 tablet twice daily or as directed by the physician Preferably taken after food to improve absorption and reduce gastric upset
Contraindications
Diarrhea Nausea or vomiting Abdominal pain Headache Rash (rare) Yeast infections (rare)
Availability
Cefpodoxime Clavulanic Acid dry syrup | Cefpodoxime 100mg + Clavulanic | Pediatric antibiotic | Broad-spectrum antibiotic for kids | Beta-lactamase resistant syrup